Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial

AIMS: After percutaneous coronary intervention (PCI) in patients with atrial fibrillation, safety and efficacy with dabigatran dual therapy were evaluated in pre-specified subgroups of patients undergoing PCI due to acute coronary syndrome (ACS) or elective PCI, and those receiving ticagrelor or clo...

Descripción completa

Detalles Bibliográficos
Autores principales: Oldgren, Jonas, Steg, Philippe Gabriel, Hohnloser, Stefan H, Lip, Gregory Y H, Kimura, Takeshi, Nordaby, Matias, Brueckmann, Martina, Kleine, Eva, ten Berg, Jurrien M, Bhatt, Deepak L, Cannon, Christopher P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514838/
https://www.ncbi.nlm.nih.gov/pubmed/30793734
http://dx.doi.org/10.1093/eurheartj/ehz059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514838/
https://www.ncbi.nlm.nih.gov/pubmed/30793734
http://dx.doi.org/10.1093/eurheartj/ehz059

Ejemplares similares